{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-122449","form_type":"8-K","ticker":"MOBX","cik":"0001855467","company_name":"MOBIX LABS, INC","filed_at":"2023-11-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.090181+00:00","generated_at":"2026-06-07T20:02:21.651278+00:00","sec_items":["1.01","2.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Chavant Capital amends SPAC merger with Mobix Labs; extends deadline to Jan 22, 2024","bullets":["Amendment No. 2 extends outside date to Jan 22, 2024, sets exchange ratio at 1:1, removes $5M net tangible assets condition.","PIPE Warrant issued for 700,000 shares of Mobix Labs at $0.01/share to ACE SO4 Holdings for consent to amendment.","Nov 30: Chavant issued $325,000 Promissory Note to sponsor at 10% interest, due upon earlier of closing or one year.","Supplemental disclosure: Mobix Labs holders expected to own ~77.5% Class A, 100% Class B, 87.4% combined voting power (no redemptions).","Public shareholders expected to hold ~2.7% Class A, initial shareholders 6.9%, PIPE investor 12.9% (no redemptions)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-122449","json":"https://secwatch.observer/filing/0001104659-23-122449.json","markdown":"https://secwatch.observer/filing/0001104659-23-122449.md","text":"https://secwatch.observer/filing/0001104659-23-122449.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855467/000110465923122449/0001104659-23-122449-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855467/000110465923122449/tm2331792d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T20:02:21.651278+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3f27083487c4d3a28a6f730ec17db2d65f72af3d","claim":"MOBIX LABS, INC incurred loan of up to $325,000 with Chavant Capital Partners LLC (the \"Sponsor\") at 10.0% per annum maturing upon the earlier of (i) the consummation of the Proposed Transaction and (ii) one year from the date of issuance.","evidence_excerpt":"On November 30, 2023, Chavant issued an unsecured note (the “Promissory Note”) in the aggregate principal amount of up to $325,000 to its sponsor, Chavant Capital Partners LLC (the “Sponsor”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855467/000110465923122449/0001104659-23-122449-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"up to $325,000"},{"label":"Counterparty","value":"Chavant Capital Partners LLC (the \"Sponsor\")"},{"label":"Rate","value":"10.0% per annum"},{"label":"Maturity","value":"upon the earlier of (i) the consummation of the Proposed Transaction and (ii) one year from the date of issuance"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"0e21bbea395283aad4a653dd83d085eca43fb2a6","claim":"MOBIX LABS, INC amended Amendment No. 2 with Chavant, Mobix Labs, Merger Sub (effective 2023-11-26).","evidence_excerpt":"Amendment No. 2 to the Business Combination Agreement On November 26, 2023, Chavant entered into Amendment No. 2 (“Amendment No.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1855467/000110465923122449/0001104659-23-122449-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Chavant, Mobix Labs, Merger Sub"},{"label":"Effective","value":"2023-11-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}